Tim Vervliet

4PUBLICATIONS
17CO-AUTHORS
ElectrometallurgyMolecular targetsCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Dec 30, 2022
Cardiomyocyte differentiation from human induced pluripotent stem cells is delayed following knockout of Bcl-2.

Tim Vervliet, Robin Duelen, Ankit Pradhan

|Sep 28, 2021
Uniting the divergent Wolfram syndrome-linked proteins WFS1 and CISD2 as modulators of Ca2+ signaling.

Jens Loncke, Tim Vervliet, Jan B Parys

|Sep 29, 2018
ABT-199 (Venetoclax), a BH3-mimetic Bcl-2 inhibitor, does not cause Ca2+ -signalling dysregulation or toxicity in pancreatic acinar cells.

Monika A Jakubowska, Martijn Kerkhofs, Claudio Martines

Pageof 1